165
views
0
recommends
+1 Recommend
1 collections
    1
    shares
      scite_
       
      • Record: found
      • Abstract: found
      • Conference Proceedings: found
      Is Open Access

      Unlocking and optimal utilization of drug repurposing patenting potential: building a wall of protection and improving the odds of successfully providing patients with new therapies

      Published
      conference-abstract
      1 ,
      ScienceOpen
      International Drug Repurposing Conference (iDR24)
      6-7 March 2024

            Abstract

            Patenting drug repurposing programs is a significant part of the NLO's pharma team of patent attorneys. Despite successes, it is common that researchers are not fully aware of the patenting possibilities, and even better, opportunities it can offer for contributing to the success: raising sufficient financial resources for amongst others clinical trials and the registration process, and ultimately reaching the goal of providing patients the new repurposed drug for solving their unmet medical needs. Therefore, the conference provides a perfect platform for sharing our insights and knowledge on drug repurposing patenting, and for fruitful discussions on the what, how and when. Do's and certainly also Don'ts will be expressed in order to optimize the odds for successful patenting and for avoiding disappointments, for example due to timely or the opposite, too late filing of patent applications. It is through meetings like this that great ideas can growth and gain momentum. We feel that contributing to the drug repurposing community is beneficial for improving the chance for success.

            Author and article information

            Conference
            ScienceOpen
            19 February 2024
            Affiliations
            [1 ] European Patent Attorney Pharma;
            Author notes
            Article
            10.14293/iDR.23.002BB
            401df425-6c48-4c1b-bd9a-c9d3faccaa73
            The Author

            Published under Creative Commons Attribution 4.0 International ( CC BY 4.0). Users are allowed to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercially), as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source.

            International Drug Repurposing Conference
            iDR24
            1
            Barcelona, Spain
            6-7 March 2024
            History
            Product

            ScienceOpen

            Categories

            Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
            Pharmacology & Pharmaceutical medicine

            Comments

            Comment on this article